Coverage

Medical devices & diagnostics

Practicing clinicians, procurement leads, and regulatory specialists who can speak to real-world adoption, not just the spec sheet.

Patient monitoring device displaying vital signs

On the bench

Practicing physicians & surgeons

Hospital procurement leads

Biomedical engineers

Regulatory affairs specialists

Clinical lab directors

What it tells you

Clinical adoption validationHow a device or assay actually fits into physician workflow, not just its clinical trial data.
Reimbursement & coding pathwayCPT/HCPCS coding strategy and payer coverage likelihood before commercial launch.
Procurement dynamicsHow hospital purchasing committees actually evaluate and switch between competing devices.
Regulatory strategyA 510(k)/PMA-experienced view on the fastest credible path to clearance.

The kind of question this answers

Will a hospital's value analysis committee actually approve switching from an incumbent device?

What CPT code is this diagnostic realistically going to bill under, and what does that mean for reimbursement?

Does the workflow disruption of this device outweigh its clinical benefit, from the surgeon's chair?

What's the real timeline a 510(k) submission like this takes, based on recent precedent?

In practice

A medtech company couldn't explain why a competing device was gaining share in community hospitals despite weaker clinical data. We put two hospital procurement leads and a practicing surgeon who'd evaluated both devices in the last twelve months in front of the actual purchasing decision, and found price and sterile-processing workflow were driving the switch. That reframed the client's commercial strategy going into their next sales cycle.

Composite example, illustrative only.